Announcements

As Current Oncology (ISSN: 1718-7729) is of an open access format, you have free and unlimited access to the full text of all articles published in our journal. We welcome you to read our 2022 top cited papers in the Section “Breast Cancer” shown below:

1. “Applying Deep Learning for Breast Cancer Detection in Radiology”
by Ella Mahoro and Moulay A. Akhloufi
Curr. Oncol. 2022, 29(11), 8767–8793; https://doi.org/10.3390/curroncol29110690
Available online: https://www.mdpi.com/1718-7729/29/11/690

2. “Breast Cancer Patients: Who Would Benefit from Neoadjuvant Chemotherapies?”
by Liqin Yao, Gang Jia, Lingeng Lu and Wenxue Ma
Curr. Oncol. 2022, 29(7), 4902–4913; https://doi.org/10.3390/curroncol29070389
Available online: https://www.mdpi.com/1718-7729/29/7/389

3. “Optimizing Adjuvant Treatment Recommendations for Older Women with Biologically Favorable Breast Cancer: Short-Course Radiation or Long-Course Endocrine Therapy?”
by Susan G. R. McDuff and Rachel C. Blitzblau
Curr. Oncol. 2023, 30(1), 392–400; https://doi.org/10.3390/curroncol30010032
Available online: https://www.mdpi.com/1718-7729/30/1/32

4. “Real-World Clinical Outcomes of Ribociclib in Combination with a Non-Steroidal Aromatase Inhibitor and a Luteinizing Hormone-Releasing Hormone Agonist in Premenopausal HR+/HER2− Advanced Breast Cancer Patients: An Italian Managed Access Program”
by Nicoletta Staropoli, Elena Geuna, Gaetana Rinaldi, Giancarlo Bisagni, Vieri Scotti, Giovanni Faggioni, Laura Vannini, Carlo Arcara, Gabriella Moretti, Marco Gunnellini et al.
Curr. Oncol. 2022, 29(9), 6635–6641; https://doi.org/10.3390/curroncol29090521
Available online: https://www.mdpi.com/1718-7729/29/9/521

5. “Are Columnar Cell Lesions the Earliest Non-Obligate Precursor in the Low-Grade Breast Neoplasia Pathway?”
by Sarah Strickland and Gulisa Turashvili
Curr. Oncol. 2022, 29(8), 5664–5681; https://doi.org/10.3390/curroncol29080447
Available online: https://www.mdpi.com/1718-7729/29/8/447

6. “Efficacy and Accuracy of Using Magnetic Seed for Preoperative Non-Palpable Breast Lesions Localization: Our Experience with Magseed”
by Anna D’Angelo, Charlotte Marguerite Lucille Trombadori, Flavia Caprini, Stefano Lo Cicero, Valentina Longo, Francesca Ferrara, Simone Palma, Marco Conti, Antonio Franco, Lorenzo Scardina et al.
Curr. Oncol. 2022, 29(11), 8468–8474; https://doi.org/10.3390/curroncol29110667
Available online: https://www.mdpi.com/1718-7729/29/11/667 

7. “Prevalence and Persistence of Anxiety and Depression over Five Years since Breast Cancer Diagnosis—The NEON-BC Prospective Study”
by Catarina Lopes, Luisa Lopes-Conceição, Filipa Fontes, Augusto Ferreira, Susana Pereira, Nuno Lunet and Natália Araújo
Curr. Oncol. 2022, 29(3), 2141–2153; https://doi.org/10.3390/curroncol29030173
Available online: https://www.mdpi.com/1718-7729/29/3/173

8. “Preoperative Radio(Chemo)Therapy in Breast Cancer: Time to Switch the Perspective?”
by Angel Montero and Raquel Ciérvide
Curr. Oncol. 2022, 29(12), 9767–9787; https://doi.org/10.3390/curroncol29120768
Available online: https://www.mdpi.com/1718-7729/29/12/768

As Current Oncology (ISSN: 1718-7729) is of an open access format, you have free and unlimited access to the full text of all articles published in our journal. We welcome you to read our 2022 top cited papers in the Section “Oncology Nursing” shown below:

1. “Equity-Oriented Healthcare: What It Is and Why We Need It in Oncology”
by Tara C. Horrill, Annette J. Browne and Kelli I. Stajduhar
Curr. Oncol. 2022, 29(1), 186–192; https://doi.org/10.3390/curroncol29010018
Available online: https://www.mdpi.com/1718-7729/29/1/18

2. “A Continuing Educational Program Supporting Health Professionals to Manage Grief and Loss”
by Mary Jane Esplen, Jiahui Wong, Mary L. S. Vachon and Yvonne Leung
Curr. Oncol. 2022, 29(3), 1461–1474; https://doi.org/10.3390/curroncol29030123
Available online: https://www.mdpi.com/1718-7729/29/3/123

3. “Risk Stratification and Cancer Follow-Up: Towards More Personalized Post-Treatment Care in Canada”
by Robin Urquhart, Wendy Cordoba, Jackie Bender, Colleen Cuthbert, Julie Easley, Doris Howell, Julia Kaal, Cynthia Kendell, Samantha Radford and Jonathan Sussman
Curr. Oncol. 2022, 29(5), 3215–3223; https://doi.org/10.3390/curroncol29050261
Available online: https://www.mdpi.com/1718-7729/29/5/261

4. “Oncology Healthcare Professionals’ Mental Health during the COVID-19 Pandemic”
by Leeat Granek and Ora Nakash
Curr. Oncol. 2022, 29(6), 4054–4067; https://doi.org/10.3390/curroncol29060323
Available online: https://www.mdpi.com/1718-7729/29/6/323

5. “Lessons Learned from the Implementation of a Person-Centred Digital Health Platform in Cancer Care”
by Saima Ahmed, Karine LePage, Renata Benc, Guy Erez, Alon Litvin, Annie Werbitt, Gabrielle Chartier, Carly Berlin and Carmen G. Loiselle
Curr. Oncol. 2022, 29(10), 7171–7180; https://doi.org/10.3390/curroncol29100564
Available online: https://www.mdpi.com/1718-7729/29/10/564

As Current Oncology (ISSN: 1718-7729) is of an open access format, you have free and unlimited access to the full text of all articles published in our journal. We welcome you to read our 2022 top cited papers in the Section “Psychosocial Oncology” shown below:

1. “The Chemo-Gut Pilot Study: Associations between Gut Microbiota, Gastrointestinal Symptoms, and Psychosocial Health Outcomes in a Cross-Sectional Sample of Young Adult Cancer Survivors”
by Julie M. Deleemans, Faye Chleilat, Raylene A. Reimer, Mohamad Baydoun, Katherine-Ann Piedalue, Dana E. Lowry, Jan-Willem Henning and Linda E. Carlson
Curr. Oncol. 2022, 29(5), 2973-2994; https://doi.org/10.3390/curroncol29050243
Available online: https://www.mdpi.com/1718-7729/29/5/243

2. “The Psychosocial Impact of COVID-19 on Older Adults with Cancer: A Rapid Review”
by Ridhi Verma, Heather M. Kilgour and Kristen R. Haase
Curr. Oncol. 2022, 29(2), 589-601; https://doi.org/10.3390/curroncol29020053
Available online: https://www.mdpi.com/1718-7729/29/2/53 

3. “Assessing the Relationship between Socioeconomic Status, Race, and Psychological Distress in Cancer Survivors: A Population Based Study”
by Ikechukwu Chidobem, Fan Tian, Chisom Mgbodile, Francis Mgbodile, Tahereh Orouji Jokar, Esther Ogbuokiri and Nazia Khan
Curr. Oncol. 2022, 29(4), 2575-2582; https://doi.org/10.3390/curroncol29040211
Available online: https://www.mdpi.com/1718-7729/29/4/211 

4. “Psychosocial Implications of COVID-19 on Head and Neck Cancer”
by Sarah M. Dermody and Andrew G. Shuman
Curr. Oncol. 2022, 29(2), 1062-1068; https://doi.org/10.3390/curroncol29020090
Available online: https://www.mdpi.com/1718-7729/29/2/90 

5. “Biopsychosocial Markers of Body Image Concerns in Patients with Head and Neck Cancer: A Prospective Longitudinal Study”
by Justine G. Albert, Christopher Lo, Zeev Rosberger, Saul Frenkiel, Michael Hier, Anthony Zeitouni, Karen Kost, Alex Mlynarek, Martin Black, Christina MacDonald et al.
Curr. Oncol. 2022, 29(7), 4438-4454; https://doi.org/10.3390/curroncol29070353
Available online: https://www.mdpi.com/1718-7729/29/7/353 

6. “Psychological Problems among Head and Neck Cancer Patients in Relation to Utilization of Healthcare and Informal Care and Costs in the First Two Years after Diagnosis”
by Florie E. van Beek, Femke Jansen, Rob J. Baatenburg de Jong, Johannes A. Langendijk, C. René Leemans, Johannes H. Smit, Robert P. Takes, Chris H. J. Terhaard, José A. E. Custers, Judith B. Prins et al.
Curr. Oncol. 2022, 29(5), 3200-3214; https://doi.org/10.3390/curroncol29050260
Available online: https://www.mdpi.com/1718-7729/29/5/260

7. “Screening for Distress and Health Outcomes in Head and Neck Cancer”
by Bryan Gascon, Aliza A. Panjwani, Olivia Mazzurco and Madeline Li
Curr. Oncol. 2022, 29(6), 3793-3806; https://doi.org/10.3390/curroncol29060304
Available online: https://www.mdpi.com/1718-7729/29/6/304

8. “Oncology Healthcare Professionals’ Mental Health during the COVID-19 Pandemic”
by Leeat Granek and Ora Nakash
Curr. Oncol. 2022, 29(6), 4054-4067; https://doi.org/10.3390/curroncol29060323
Available online: https://www.mdpi.com/1718-7729/29/6/323

As Current Oncology (ISSN: 1718-7729) is of an open access format, you have free and unlimited access to the full text of all articles published in our journal. We welcome you to read our 2022 top cited papers in the Section “Hematology” below:

1. “Primary Diffuse Large B-Cell Lymphoma of the Urinary Bladder: Update on a Rare Disease and Potential Diagnostic Pitfalls”
by Magda Zanelli, Francesca Sanguedolce, Maurizio Zizzo, Andrea Palicelli, David Pellegrini, Sabrina Farinacci, Alessandra Soriano, Elisabetta Froio, Luigi Cormio, Giuseppe Carrieri et al.
Curr. Oncol. 2022, 29(2), 956–968; https://doi.org/10.3390/curroncol29020081
Available online: https://www.mdpi.com/1718-7729/29/2/81

2. “Comprehensive Laboratory Diagnostic Workup for Patients with Suspected Intraocular Lymphoma including Flow Cytometry, Molecular Genetics and Cytopathology”
by Evgenii Shumilov, Paolo Mazzeo, Martin S. Zinkernagel, Myriam Legros, Naomi Porret, Lorenz Romagna, Detlef Haase, Georg Lenz, Urban Novak, Yara Banz et al.
Curr. Oncol. 2022, 29(2), 766–776; https://doi.org/10.3390/curroncol29020065
Available online: https://www.mdpi.com/1718-7729/29/2/65

3. “Two Distinct Clinical Patterns of Ibrutinib-to-Venetoclax Transition in Relapsed Chronic Lymphocytic Leukemia Patients”
by Isacco Ferrarini, Francesca Gandini, Ettore Zapparoli and Antonella Rigo
Curr. Oncol. 2022, 29(4), 2792–2797; https://doi.org/10.3390/curroncol29040227
Available online: https://www.mdpi.com/1718-7729/29/4/227

4. “The Use of Virtual Care in Patients with Hematologic Malignancies: A Scoping Review”
by Adam Suleman, Abi Vijenthira, Alejandro Berlin, Anca Prica and Danielle Rodin
Curr. Oncol. 2022, 29(2), 892–900; https://doi.org/10.3390/curroncol29020076
Available online: https://www.mdpi.com/1718-7729/29/2/76

6. “Concurrent Waldenstrom’s Macroglobulinemia and Myelodysplastic Syndrome with a Sequent t(10;13)(p13;q22) Translocation”
by Peter A. DeRosa, Kyle C. Roche, Victor E. Nava, Sunita Singh, Min-Ling Liu and Anita Agarwal
Curr. Oncol. 2022, 29(7), 4587–4592; https://doi.org/10.3390/curroncol29070363
Available online: https://www.mdpi.com/1718-7729/29/7/363

7. “Diffuse Large B Cell Lymphoma Arising in Patients with Preexisting Hodgkin Lymphoma”
by Emilio Bellitti, Pierluigi Masciopinto, Pellegrino Musto, Elena Arcuti, Luca Mastracci, Giuseppina Opinto, Sabino Ciavarella, Attilio Guarini, Gerardo Cazzato, Giorgina Specchia et al.
Curr. Oncol. 2022, 29(9), 6115–6124; https://doi.org/10.3390/curroncol29090480
Available online: https://www.mdpi.com/1718-7729/29/9/480

8. “Total Body Irradiation for Hematopoietic Stem Cell Transplantation: What Can We Agree on?”
by Mitchell Sabloff, Steven Tisseverasinghe, Mustafa Ege Babadagli and Rajiv Samant
Curr. Oncol. 2021, 28(1), 903–917; https://doi.org/10.3390/curroncol28010089
Available online: https://www.mdpi.com/1718-7729/28/1/89

9. “Primary Vitreoretinal Lymphoma: Current Diagnostic Laboratory Tests and New Emerging Molecular Tools”
by Beatrice Melli, Pietro Gentile, Davide Nicoli, Enrico Farnetti, Stefania Croci, Fabrizio Gozzi, Elena Bolletta, Luca De Simone, Francesca Sanguedolce, Andrea Palicelli et al.
Curr. Oncol. 2022, 29(10), 6908–6921; https://doi.org/10.3390/curroncol29100543
Available online: https://www.mdpi.com/1718-7729/29/10/543

10. “Treating Multiple Myeloma in the Context of the Bone Marrow Microenvironment”
by Matthew Ho, Alexander Xiao, Dongni Yi, Saurabh Zanwar and Giada Bianchi
Curr. Oncol. 2022, 29(11), 8975–9005; https://doi.org/10.3390/curroncol29110705
Available online: https://www.mdpi.com/1718-7729/29/11/705

As Current Oncology (ISSN: 1718-7729) is of an open access format, you have free and unlimited access to the full text of all articles published in our journal. We welcome you to read our 2022 top cited papers in the Section “Surgical Oncology” below:

1. “Outcomes of Enhanced Recovery after Surgery (ERAS) in Gynecologic Oncology: A Review”
by Steven P. Bisch and Gregg Nelson
Curr. Oncol. 2022, 29(2), 631–640; https://doi.org/10.3390/curroncol29020056
Available online: https://www.mdpi.com/1718-7729/29/2/56

2. “Systemic Therapy and Its Surgical Implications in Patients with Resectable Liver Colorectal Cancer Metastases. A Report from the Western Canadian Gastrointestinal Cancer Consensus Conference”
by Shahid Ahmed, Nicholas Bosma, Michael Moser, Shahida Ahmed, Bryan Brunet, Janine Davies, Corinne Doll, Dorie-Anna Dueck, Christina A. Kim, Shuying Ji et al.
Curr. Oncol. 2022, 29(3), 1796–1807; https://doi.org/10.3390/curroncol29030147
Available online: https://www.mdpi.com/1718-7729/29/3/147

3. “Challenges in Geriatric Oncology—A Surgeon’s Perspective”
by Ruth Parks and Kwok-Leung Cheung
Curr. Oncol. 2022, 29(2), 659–674; https://doi.org/10.3390/curroncol29020058
Available online: https://www.mdpi.com/1718-7729/29/2/58

4. “The Prediction of Survival after Surgical Management of Bone Metastases of the Extremities—A Comparison of Prognostic Models”
by Ofir Gal Ben, Terrence Chi Fang Soh, Sarah Vaughan, Viswanath Jayasanker, Ashish Mahendra and Sanjay Gupta
Curr. Oncol. 2022, 29(7), 4703–4716; https://doi.org/10.3390/curroncol29070373
Available online: https://www.mdpi.com/1718-7729/29/7/373

5. “Minimally Invasive Surgery for Cervical Cancer in Light of the LACC Trial: What Have We Learned?”
by Omar Touhami and Marie Plante
Curr. Oncol. 2022, 29(2), 1093–1106; https://doi.org/10.3390/curroncol29020093
Available online: https://www.mdpi.com/1718-7729/29/2/93

6. “A Qualitative Study of Patient and Healthcare Provider Perspectives on Building Multiphasic Exercise Prehabilitation into the Surgical Care Pathway for Head and Neck Cancer”
by Julia T. Daun, Rosie Twomey, Joseph C. Dort, Lauren C. Capozzi, Trafford Crump, George J. Francis, T. Wayne Matthews, Shamir P. Chandarana, Robert D. Hart, Christiaan Schrag et al.
Curr. Oncol. 2022, 29(8), 5942–5954; https://doi.org/10.3390/curroncol29080469
Available online: https://www.mdpi.com/1718-7729/29/8/469

7. “Surgical Treatment of Distal Cholangiocarcinoma”
by Leva Gorji and Eliza W. Beal
Curr. Oncol. 2022, 29(9), 6674–6687; https://doi.org/10.3390/curroncol29090524
Available online: https://www.mdpi.com/1718-7729/29/9/524 

8. “Upfront Chemotherapy Followed by Stereotactic Body Radiation Therapy with or without Surgery in Older Patients with Localized Pancreatic Cancer: A Single Institution Experience and Review of the Literature”
by Abhinav V. Reddy, Shuchi Sehgal, Colin S. Hill, Lei Zheng, Jin He, Joseph M. Herman, Jeffrey Meyer and Amol K. Narang
Curr. Oncol. 2022, 29(1), 308–320; https://doi.org/10.3390/curroncol29010028
Available online: https://www.mdpi.com/1718-7729/29/1/28 

9. “The Role of Surgical Approaches in the Multi-Modal Management of Adult Craniopharyngiomas”
by Christopher S. Hong and Sacit Bulent Omay
Curr. Oncol. 2022, 29(3), 1408–1421; https://doi.org/10.3390/curroncol29030118
Available online: https://www.mdpi.com/1718-7729/29/3/118

10. “Surgical Management of Craniovertebral Junction Schwannomas: A Systematic Review”
by Paolo Palmisciano, Gianluca Ferini, Gina Watanabe, Andie Conching, Christian Ogasawara, Gianluca Scalia, Othman Bin-Alamer, Ali S. Haider, Maurizio Passanisi, Rosario Maugeri et al.
Curr. Oncol. 2022, 29(7), 4842–4855; https://doi.org/10.3390/curroncol29070384
Available online: https://www.mdpi.com/1718-7729/29/7/384

As Current Oncology (ISSN: 1718-7729) is of an open access format, you have free and unlimited access to the full text of all articles published in our journal. We welcome you to read our 2022 top cited papers in the Section “Palliative and Supportive Care” below:

1. “Satisfaction with Telemedicine for Cancer Pain Management: A Model of Care and Cross-Sectional Patient Satisfaction Study”
by Marco Cascella, Sergio Coluccia, Mariacinzia Grizzuti, Maria Cristina Romano, Gennaro Esposito, Anna Crispo and Arturo Cuomo
Curr. Oncol. 2022, 29(8), 5566–5578; https://doi.org/10.3390/curroncol29080439
Available online: https://www.mdpi.com/1718-7729/29/8/439

2. “Point of Care Molecular Testing: Community-Based Rapid Next-Generation Sequencing to Support Cancer Care”
by Brandon S. Sheffield, Andrea Beharry, Joanne Diep, Kirstin Perdrizet, Marco A. J. Iafolla, William Raskin, Shaan Dudani, Mary Anne Brett, Blerta Starova, Brian Olsen et al.
Curr. Oncol. 2022, 29(3), 1326–1334; https://doi.org/10.3390/curroncol29030113
Available online: https://www.mdpi.com/1718-7729/29/3/113

3. “Effect of COVID-19 Pandemic on Hepatocellular Carcinoma Diagnosis: Results from a Tertiary Care Center in North-West Italy”
by Davide Giuseppe Ribaldone, Gian Paolo Caviglia, Silvia Gaia, Emanuela Rolle, Alessandra Risso, Daniela Campion, Paola Rita Brunocilla, Giorgio Maria Saracco and Patrizia Carucci
Curr. Oncol. 2022, 29(3), 1422–1429; https://doi.org/10.3390/curroncol29030119
Available online: https://www.mdpi.com/1718-7729/29/3/119

4. “The Psychosocial Impact of COVID-19 on Older Adults with Cancer: A Rapid Review”
by Ridhi Verma, Heather M. Kilgour and Kristen R. Haase
Curr. Oncol. 2022, 29(2), 589–601; https://doi.org/10.3390/curroncol29020053
Available online: https://www.mdpi.com/1718-7729/29/2/53

5. “The Use of Virtual Care in Patients with Hematologic Malignancies: A Scoping Review”
by Adam Suleman, Abi Vijenthira, Alejandro Berlin, Anca Prica and Danielle Rodin
Curr. Oncol. 2022, 29(2), 892–900; https://doi.org/10.3390/curroncol29020076
Available online: https://www.mdpi.com/1718-7729/29/2/76

6. “Patient and Physician Satisfaction with Telemedicine in Cancer Care in Saskatchewan: A Cross-Sectional Study”
by Hurria Gondal, Tahir Abbas, Heather Choquette, Duc Le, Haji Ibraheem Chalchal, Nayyer Iqbal and Shahid Ahmed
Curr. Oncol. 2022, 29(6), 3870–3880; https://doi.org/10.3390/curroncol29060309
Available online: https://www.mdpi.com/1718-7729/29/6/309

7. “Tailoring the Evidence for Exercise Oncology within Breast Cancer Care”
by Chad W. Wagoner, Lauren C. Capozzi and S. Nicole Culos-Reed
Curr. Oncol. 2022, 29(7), 4827–4841; https://doi.org/10.3390/curroncol29070383
Available online: https://www.mdpi.com/1718-7729/29/7/383

8. “Treatment of Older Adult Patients with Glioblastoma: Moving towards the Inclusion of a Comprehensive Geriatric Assessment for Guiding Management”
by Manik Chahal, Brian Thiessen and Caroline Mariano
Curr. Oncol. 2022, 29(1), 360–376; https://doi.org/10.3390/curroncol29010032
Available online: https://www.mdpi.com/1718-7729/29/1/32

9. “Challenges in Geriatric Oncology—A Surgeon’s Perspective”
by Ruth Parks and Kwok-Leung Cheung
Curr. Oncol. 2022, 29(2), 659–674; https://doi.org/10.3390/curroncol29020058
Available online: https://www.mdpi.com/1718-7729/29/2/58

10. “Understanding the Post-Treatment Concerns of Cancer Survivors with Five Common Cancers: Exploring the Alberta Results from the Pan-Canadian Transitions Study”
by Claire Link, Andrea DeIure and Linda Watson
Curr. Oncol. 2022, 29(4), 2662–2680; https://doi.org/10.3390/curroncol29040218
Available online: https://www.mdpi.com/1718-7729/29/4/218

As Current Oncology (ISSN: 1718-7729) is of an open access format, you have free and unlimited access to the full text of all articles published in our journal. We welcome you to read our 2022 top cited papers in the Section “Cell Therapy” below:

1. “A Portrait of SARS-CoV-2 Infection in Patients Undergoing Hematopoietic Cell Transplantation: A Systematic Review of the Literature”
by Adrian J. M. Bailey, Aidan M. Kirkham, Madeline Monaghan, Risa Shorr, C. Arianne Buchan, Christopher Bredeson and David S. Allan
Curr. Oncol. 2022, 29(1), 337-349; https://doi.org/10.3390/curroncol29010030
Available online: https://www.mdpi.com/1718-7729/29/1/30

2. “A Scoping Review on Outcomes and Outcome Measurement Instruments in Rehabilitative Interventions for Patients with Haematological Malignancies Treated with Allogeneic Stem Cell Transplantation”
by Anastasios I. Manettas, Panagiotis Tsaklis, Dario Kohlbrenner and Lidwine B. Mokkink
Curr. Oncol. 2022, 29(7), 4998-5025; https://doi.org/10.3390/curroncol29070397
Available online: https://www.mdpi.com/1718-7729/29/7/397

3. “Cost-Effectiveness of Brexucabtagene Autoleucel versus Best Supportive Care for the Treatment of Relapsed/Refractory Mantle Cell Lymphoma following Treatment with a Bruton’s Tyrosine Kinase Inhibitor in Canada”
by Graeme Ball, Christopher Lemieux, David Cameron and Matthew D. Seftel
Curr. Oncol. 2022, 29(3), 2021-2045; https://doi.org/10.3390/curroncol29030164
Available online: https://www.mdpi.com/1718-7729/29/3/164

4. “Abstracts of the Cell Therapy Transplant Canada 2022 Annual Conference”
by Stephanie A. Maier, Tobias Berg, Susan Berrigan, Jonathan Bramson, Chris Bredeson, Guy Cantin, Andrew Daly, Gwynivere A. Davies, Mahmoud Elsawy, Alejandro Garcia-Horton et al.
Curr. Oncol. 2022, 29(12), 9970-10017; https://doi.org/10.3390/curroncol29120783
Available online: https://www.mdpi.com/1718-7729/29/12/783

5. “Access to Hematopoietic Stem Cell Transplant in Canada for Patients with Acute Myeloid”
by Oluwatobiloba Morakinyo, Oliver Bucher and Kristjan Paulson
Curr. Oncol. 2022, 29(8), 5198-5208; https://doi.org/10.3390/curroncol29080412
Available online: https://www.mdpi.com/1718-7729/29/8/412

6. “Donor Age and Non-Relapse Mortality: Study of Their Association after HLA-Matched Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndrome”
by Yasmine Kadri, Michelle Phan, Nadia Bambace, Léa Bernard, Sandra Cohen, Jean-Sébastien Delisle, Thomas Kiss, Sylvie Lachance, Denis-Claude Roy, Guy Sauvageau et al.
Curr. Oncol. 2022, 29(8), 5955-5962; https://doi.org/10.3390/curroncol29080470
Available online: https://www.mdpi.com/1718-7729/29/8/470

As Current Oncology (ISSN: 1718-7729) is of an open access format, you have free and unlimited access to the full text of all articles published in our journal. We welcome you to read our 2022 top cited papers in the Section “Medical Oncology” below: 

1. “Optimization of the Clinical Effectiveness of Radioembolization in Hepatocellular Carcinoma with Dosimetry and Patient-Selection Criteria”
by Philippe d’Abadie, Stephan Walrand, Renaud Lhommel, Michel Hesse, Ivan Borbath and François Jamar
Curr. Oncol. 2022, 29(4), 2422-2434; https://doi.org/10.3390/curroncol29040196
Available online: https://www.mdpi.com/1718-7729/29/4/196

2. “Health Literacy and Clinical Trial Participation in French Cancer Patients: A National Survey”
by Youssoufa M. Ousseine, Anne-Déborah Bouhnik and Julien Mancini
Curr. Oncol. 2022, 29(5), 3118-3129; https://doi.org/10.3390/curroncol29050253
Available online: https://www.mdpi.com/1718-7729/29/5/253 

3. “5-Fluorouracil/L-Leucovorin Plus Oxaliplatin (FOLFOX) Regimen as Salvage Chemotherapy for Patients with Unresectable Pancreatic Cancer Receiving Gemcitabine and Nab-Paclitaxel and 5-Fluorouracil/L-Leucovorin Plus Nanoliposomal Irinotecan: Preliminary Results from Clinical Practice”
by Takuo Yamai, Kenji Ikezawa, Yasuharu Kawamoto, Takeru Hirao, Sena Higashi, Kazuma Daiku, Shingo Maeda, Yutaro Abe, Makiko Urabe, Yugo Kai et al.
Curr. Oncol. 2022, 29(4), 2644-2649; https://doi.org/10.3390/curroncol29040216
Available online: https://www.mdpi.com/1718-7729/29/4/216

4. “Novel, First-in-Human, Oral PCLX-001 Treatment in a Patient with Relapsed Diffuse Large B-Cell Lymphoma”
by Randeep Sangha, Neal M. Davies, Afshin Namdar, Michael Chu, Jennifer Spratlin, Erwan Beauchamp, Luc G. Berthiaume and John R. Mackey
Curr. Oncol. 2022, 29(3), 1939-1946; https://doi.org/10.3390/curroncol29030158
Available online: https://www.mdpi.com/1718-7729/29/3/158

5. “Real-World Adherence to Toxicity Management Guidelines for Immune-Related Adverse Events”
by Arezou Teimouri, Laura V. Minard, Samantha N. Scott, Amanda Daniels and Stephanie Snow
Curr. Oncol. 2022, 29(5), 3104-3117; https://doi.org/10.3390/curroncol29050252
Available online: https://www.mdpi.com/1718-7729/29/5/252

6. “Clinical Utility of Multigene Profiling Assays in Early-Stage Invasive Breast Cancer: An Ontario Health (Cancer Care Ontario) Clinical Practice Guideline”
by Phillip Blanchette, Duvaraga Sivajohanathan, John Bartlett, Andrea Eisen, Harriet Feilotter, Rossanna Pezo, Gulisa Turashvili and Phillip Williams
Curr. Oncol. 2022, 29(4), 2599-2615; https://doi.org/10.3390/curroncol29040213
Available online: https://www.mdpi.com/1718-7729/29/4/213

7. “Gynecologic Symptoms among Hormone Receptor-Positive Breast Cancer Patients on Oral Endocrine Therapy: A Cross-Sectional Study”
by Alexandra Moskalewic, Amy Di Tomaso, Jacob J. Kachura, Samantha Scime, Rosane Nisenbaum, Ronita Lee, Rashida Haq, Christine Derzko and Christine Brezden-Masley
Curr. Oncol. 2022, 29(3), 1813-1827; https://doi.org/10.3390/curroncol29030149
Available online: https://www.mdpi.com/1718-7729/29/3/149 

8. “The Clinical Impact of Neoadjuvant Endocrine Treatment on Luminal-like Breast Cancers and Its Prognostic Significance: Results from a Single-Institution Prospective Cohort Study”
by Covadonga Martí, Laura Yébenes, José María Oliver, Elisa Moreno, Laura Frías, Alberto Berjón, Adolfo Loayza, Marcos Meléndez, María José Roca, Vicenta Córdoba et al.
Curr. Oncol. 2022, 29(4), 2199-2210; https://doi.org/10.3390/curroncol29040179
Available online: https://www.mdpi.com/1718-7729/29/4/179

9. “Routine Screening for Central and Primary Adrenal Insufficiency during Immune-Checkpoint Inhibitor Therapy: An Endocrinology Perspective for Oncologists”
by Irena Druce, Karine Tawagi, Julie L. V. Shaw, Andrea Ibrahim, Heather Lochnan and Michael Ong
Curr. Oncol. 2022, 29(7), 4665-4677; https://doi.org/10.3390/curroncol29070370
Available online: https://www.mdpi.com/1718-7729/29/7/370

World Lymphoma Awareness Day (WLAD) takes place annually on September 15th. It is organized by the Lymphoma Coalition and was established in 2004 with the purpose of promoting public understanding of the various subtypes of lymphoma. Its primary objectives include educating people about recognizing symptoms, encouraging early diagnosis, and emphasizing the importance of timely treatment.

For World Lymphoma Awareness Day 2023, Current Oncology (ISSN: 1718-7729) has gathered open access academic research on the topic of lymphoma. We hope to share new scientific knowledge in the field of lymphoma with the world on this special day.

1. “CD5-Negative, CD10-Negative Low-Grade B-Cell Lymphoproliferative Disorders of the Spleen”
by John J. Schmieg, Jeannie M. Muir, Nadine S. Aguilera and Aaron Auerbach
Curr. Oncol. 2021, 28(6), 5124–5147; https://doi.org/10.3390/curroncol28060430
Available online: https://www.mdpi.com/1718-7729/28/6/430

2. “How to Diagnose and Treat CD5-Positive Lymphomas Involving the Spleen”
by José Cabeçadas, Victor E. Nava, Joao L. Ascensao and Maria Gomes da Silva
Curr. Oncol. 2021, 28(6), 4611–4633; https://doi.org/10.3390/curroncol28060390
Available online: https://www.mdpi.com/1718-7729/28/6/390

3. “A Review on Splenic Diffuse Red Pulp Small B-Cell Lymphoma”
by Elif Yilmaz, Arashpreet Chhina, Victor E. Nava and Anita Aggarwal
Curr. Oncol. 2021, 28(6), 5148–5154; https://doi.org/10.3390/curroncol28060431
Available online: https://www.mdpi.com/1718-7729/28/6/431

4. “Low-Grade Primary Splenic CD10-Positive Small B-Cell Lymphoma/Follicular Lymphoma”
by Rami Abdulbaki, Parastou Tizro, Victor E. Nava, Maria Gomes da Silva and João L. Ascensão
Curr. Oncol. 2021, 28(6), 4821–4831; https://doi.org/10.3390/curroncol28060407
Available online: https://www.mdpi.com/1718-7729/28/6/407

5. “Comprehensive Laboratory Diagnostic Workup for Patients with Suspected Intraocular Lymphoma including Flow Cytometry, Molecular Genetics and Cytopathology”
by Evgenii Shumilov, Paolo Mazzeo, Martin S. Zinkernagel, Myriam Legros, Naomi Porret, Lorenz Romagna, Detlef Haase, Georg Lenz, Urban Novak, Yara Banz et al.
Curr. Oncol. 2022, 29(2), 766–776; https://doi.org/10.3390/curroncol29020065
Available online: https://www.mdpi.com/1718-7729/29/2/65

6. “Intravascular Large B-Cell Lymphoma: A Review with a Focus on the Prognostic Value of Skin Involvement”
by Thomas Breakell, Heidi Waibel, Stefan Schliep, Barbara Ferstl, Michael Erdmann, Carola Berking and Markus V. Heppt
Curr. Oncol. 2022, 29(5), 2909–2919; https://doi.org/10.3390/curroncol29050237
Available online: https://www.mdpi.com/1718-7729/29/5/237

7. “Management of Marginal Zone Lymphoma: A Canadian Perspective”
by Anthea Peters, Mary-Margaret Keating, Anna Nikonova, Sarah Doucette and Anca Prica
Curr. Oncol. 2023, 30(2), 1745–1759; https://doi.org/10.3390/curroncol30020135
Available online: https://www.mdpi.com/1718-7729/30/2/135

8. “Cost-Effectiveness of Brexucabtagene Autoleucel versus Best Supportive Care for the Treatment of Relapsed/Refractory Mantle Cell Lymphoma following Treatment with a Bruton’s Tyrosine Kinase Inhibitor in Canada”
by Graeme Ball, Christopher Lemieux, David Cameron and Matthew D. Seftel
Curr. Oncol. 2022, 29(3), 2021–2045; https://doi.org/10.3390/curroncol29030164
Available online: https://www.mdpi.com/1718-7729/29/3/164

9. “Novel, First-in-Human, Oral PCLX-001 Treatment in a Patient with Relapsed Diffuse Large B-Cell Lymphoma”
by Randeep Sangha, Neal M. Davies, Afshin Namdar, Michael Chu, Jennifer Spratlin, Erwan Beauchamp, Luc G. Berthiaume and John R. Mackey
Curr. Oncol. 2022, 29(3), 1939–1946; https://doi.org/10.3390/curroncol29030158
Available online: https://www.mdpi.com/1718-7729/29/3/158

10. “Novel Mutations in a Lethal Case of Lymphomatous Adult T Cell Lymphoma with Cryptic Myocardial Involvement”
by Taraneh Hashemi Zonouz, Rami Abdulbaki, Bidhan C. Bandyopadhyay and Victor E. Nava
Curr. Oncol. 2021, 28(1), 818–824; https://doi.org/10.3390/curroncol28010079
Available online: https://www.mdpi.com/1718-7729/28/1/79

We are pleased to announce the official social media of Current Oncology:

• Twitter: https://twitter.com/CurrentOncology
• Facebook: https://www.facebook.com/CurrentOncologyMDPI
• LinkedIn: https://www.linkedin.com/company/current-oncology-mdpi

You are more than welcome to connect with us!